Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06223828
PHASE2/PHASE3

Azithromycin for Critical Asthma - Pediatrics

Sponsor: Johns Hopkins All Children's Hospital

View on ClinicalTrials.gov

Summary

The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.

Official title: Azithromycin as Immunomodulation Among Children Hospitalized for Critical Asthma: A Prospective, Open-Label, Non-Randomized, Interventional Study With Parallel Biospecimen Banking

Key Details

Gender

All

Age Range

3 Years - 17 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2024-04-02

Completion Date

2026-12-31

Last Updated

2025-12-17

Healthy Volunteers

No

Interventions

DRUG

Azithromycin

10mg/kg/dose (max dose 500mg) once daily for 3 days

Locations (1)

Johns Hopkins All Children's Hospital

St. Petersburg, Florida, United States